menu search

XAIR / Beyond Air Shares Fall As US Launch Of LungFit PH Not Expected In 2021

Beyond Air Shares Fall As US Launch Of LungFit PH Not Expected In 2021
Beyond Air Inc (NASDAQ: XAIR) expects a delay in FDA approval for LungFit PH for persistent pulmonary hypertension of the newborn. Based on ongoing communications with the FDA, the company no longer believes that the U.S. commercial launch of LungFit PH will take place before December 31, 2021. Read More
Posted: Dec 9 2021, 13:28
Author Name: Benzinga
Views: 092018

XAIR News  

Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

By GlobeNewsWire
October 4, 2023

Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that i more_horizontal

Beyond Air, Inc. (XAIR) Q1 2024 Earnings Call Transcript

By Seeking Alpha
August 10, 2023

Beyond Air, Inc. (XAIR) Q1 2024 Earnings Call Transcript

Beyond Air, Inc. (NASDAQ:XAIR ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Rela more_horizontal

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

By Zacks Investment Research
August 10, 2023

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to los more_horizontal

Beyond Air: Dilution Remains A Concern

By Seeking Alpha
June 26, 2023

Beyond Air: Dilution Remains A Concern

Today, we take a look at an interesting small-cap medical device concern called Beyond Air, Inc. The company is just rolling out its first approved pr more_horizontal

Beyond Air, Inc. (XAIR) Q4 2023 Earnings Call Transcript

By Seeking Alpha
June 22, 2023

Beyond Air, Inc. (XAIR) Q4 2023 Earnings Call Transcript

Beyond Air, Inc. (NASDAQ:XAIR ) Q4 2023 Earnings Conference Call June 22, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Relati more_horizontal

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue Estimates

By Zacks Investment Research
June 22, 2023

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to los more_horizontal

Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

By GlobeNewsWire
May 16, 2023

Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company f more_horizontal

5 Stocks Insiders Have Built Positions in Over the Past 3 Months

By GuruFocus
April 18, 2023

5 Stocks Insiders Have Built Positions in Over the Past 3 Months

According to the Insider Cluster Buys Screen, a Premium feature of GuruFocus, five stocks that have high number of unique insider buys over the past t more_horizontal


Search within

Pages Search Results: